News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
AACR25 Session Recordings Available On-Demand Through October 31
AACR/X
Jun 30, 2025, 07:38

AACR25 Session Recordings Available On-Demand Through October 31

AACR shared on X:

“AACR25 session recordings are still available to meeting registrants for on-demand viewing through Friday, October 31. Registration is also open until Monday, June 30 for new users who wish to purchase access to these recordings.

Learn more.”

AACR AACR25 cancer OncoDaily Oncology
Special Coverage
Insight
Jun 30, 2025, 07:38
Progress Made, But More Action Needed: João Breda's Message at the ELLOK 2nd Synergies Forum on Cancer Care
Blog
Jun 30, 2025, 07:38
AACR25 Session Recordings Available On-Demand Through October 31
Blog
Jun 30, 2025, 07:33
David Planchard: A wonderful day of presentations and discussions on thoracic oncology at H.I.Albert Einstein
Blog
Jun 30, 2025, 07:22
Petros Grivas: Grateful for Another Amazing Athens Meeting With Top Scientific and Social Agenda
Blog
Jun 30, 2025, 07:09
Katie Coleman Marks Four-Year Milestone After Surviving Rare Stage IV Cancer at 29
Insight
Jun 30, 2025, 06:57
Diego A. Díaz García Reflects on Nature Study Highlighting Challenges in Targeting Tumor-Infiltrating Tregs
Blog
Jun 30, 2025, 06:37
Lisa Lacasse: "This is the First Time I’ve Felt an Existential Crisis in Our Ability to Make Progress"
Dialogues
Jun 30, 2025, 06:33
Beyond the cancer diagnosis: Interview with Janet de Groot, hosted by Adrian Pogacian
Blog
Jun 30, 2025, 06:24
Stephen V. Liu Shares Phase II Data on First-Line Cisplatin, Irinotecan, and Durvalumab in SCLC
Blog
Jun 30, 2025, 06:19
Rawad Elias Marks Completion of ASCO Leadership Development Program
Blog
Jun 30, 2025, 06:18
Elizabeth Ugwoma Awo-Ejeh Shared Powerful Message of Hope for Cancer Survivors
Dialogues
Jun 30, 2025, 06:07
Top Biotechs at ASCO: Michelle Xia on Building Akeso and Advancing Dual-Target Immunotherapy